Status:
UNKNOWN
Same-day Antiretroviral Therapy With BIC/F/TAF
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Far Eastern Memorial Hospital
Mackay Memorial Hospital
Conditions:
HIV Infections
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
WHO had recommened rapid ART initiation, defined as starting ART within 7 days or on the same day after HIV diagnosis, to improve HIV care continuum. Prior studies revealed that point-of-care diagnost...
Detailed Description
Background In 2015, WHO recommended that all patients be treated with combination antiretroviral therapy (cART) once the diagnosis of HIV infection was made. On the population level, starting cART soo...
Eligibility Criteria
Inclusion
- Patients who test positive by HIV screening tests (4th generation Ag/Ab) by clinical care providers or by VCT counselors within 3 days of Visit 1.
- Aged 20 years or older
- Patient is willing to participate in this study and sign the written informed consent form
Exclusion
- Prior HIV diagnosis
- Prior ART for HIV infection
- Chronic kidney disease, stage ≥4 (CCr \<30 ml/min/1.73m2) or receiving dialysis
- Severe hepatic impairment (Child-Pugh score C) or clinical apparent hepatic impairment including jaundice or ascites
- Active or latent tuberculosis infection or clinical apparent central nervous system infection
- Pregnancy or breastfeeding
- Allergy to FTC or TDF containing medication
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04712058
Start Date
January 20 2021
End Date
January 31 2023
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100